Lv2
130 积分 2025-07-31 加入
CRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trial
3个月前
已完结
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
3个月前
已完结
Anti-B-cell maturation antigen chimeric antigen receptor T-cell therapy bb21217 for relapsed and refractory multiple myeloma: results from the phase 1 CRB-402 study
4个月前
已关闭
OA-47 Additional analysis of CARTITUDE-4: Cilta-cel vs standard of care (PVd or DPd) in lenalidomide-refractory patients with multiple myeloma and 1–3 prior lines of therapy
4个月前
已关闭
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
4个月前
已完结
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
4个月前
已完结
Investigation of mRNA Cell Therapy as a Treatment for Autoimmune Disease in Patients with Myastenia Gravis
4个月前
已关闭
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
4个月前
已完结
Characterization of B cell reset following B cell depleting therapies
4个月前
已完结
皖公网安备34019202002308
